For decades, the standard treatment in the US was "Occlusion Therapy" (patching the strong eye). However, in 2026, the American Academy of Ophthalmology (AAO) has shifted its focus toward Binocular Digital Therapeutics.

Traditional patching often faces low compliance due to social stigma and discomfort. Modern therapies utilize "Dichoptic" viewing, where both eyes are active, but the visual input is balanced—the stronger eye receives a dimmed image while the weaker eye receives high-contrast stimulation. This forces the brain to integrate signals from both eyes simultaneously, treating the root cause (the neurological suppression) rather than just the symptom.